PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
March 26, 2026BMC NeuroscienceOpen Access

Pretreatment with the psychedelic DOI mitigates LPS-induced hippocampal inflammation and behavioral impairments in mice

View Full Paper
Ask AI
Bookmark
Share

Authors

MFMichael FiorilloJGJavier González-Maeso

Discussion

Loading...

Member takes

Overview

Prophylactic DOI treatment mitigates hippocampal inflammation and behavioral impairments in mice, suggesting potential therapeutic applications.

Key Points

  • The study aims to determine if the psychedelic DOI can prevent neuroinflammation and related behavioral deficits in mice.
  • Wild-type and 5-HT2AR knockout mice were used.
  • Mice received LPS to induce neuroinflammation at different time points.
  • DOI was administered 24 hours prior to LPS challenge to assess prophylactic effects.
  • Cytokine levels were quantified via multiplex assays, and behavioral assays measured effects.
  • LPS treatment significantly increased IL-6 and TNF-α levels and caused behavioral deficits.
  • DOI pretreatment reduced inflammatory cytokines and improved locomotor and behavioral outcomes.
  • 5-HT2AR-KO mice showed heightened cytokine responses suggesting partial receptor independence.
  • Correlation between cytokine levels and behavior indicates a link between inflammation and depressive-like symptoms.

Cite This Study

Fiorillo et al. (2026) studied this question.

synapsesocial.com/papers/69c4cd25fdc3bde448919107https://doi.org/10.1186/s12868-026-01003-8
View Full Paper
Ask AI
Bookmark
Share